Cargando…
A single, clinically relevant dose of the GABA(B) agonist baclofen impairs visuomotor learning
The GABA(B) agonist baclofen is taken daily as a treatment for spasticity by millions of stroke, brain injury and multiple sclerosis patients, many of whom are also undergoing motor rehabilitation. However, decreases in GABA are suggested to be a key feature of human motor learning, which raises que...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611062/ https://www.ncbi.nlm.nih.gov/pubmed/33085094 http://dx.doi.org/10.1113/JP280378 |